Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

AMSC ASA - Second quarter and half-year 2024 Report

Lysaker, 16 July 2024, AMSC ASA (“AMSC” or the “Company”) announces results for the second quarter and half-year ending 30 June 2024. HIGHLIGHTS · Participated with NOK 122 million in the Solstad Maritime Holding (“Solstad Maritime”) private placement · Recognized share of profit of NOK 248.9 million relating to the investment in Solstad Maritime. · Declared Q2 2024 dividend of NOK 0.55 per share. AMSC CEO, Pål Lothe Magnussen comments, “We are pleased to have capitalized on the opportunity to grow our exposure to Solstad Maritime having acquired and exercised

Solstad Offshore ASA financial report for the 2nd quarter & 1st half year 2024

· On 19 June 2024 the MNOK 750 share issue in Solstad Maritime towards eligible shareholders in Solstad Offshore ASA was completed. This concluded the “Refinancing” of Solstad Offshore ASA. · Solstad Offshore completed the refinancing of the vessel Normand Superior during 2Q 2024. The new financing is extended to May 2028 · Solstad Offshore achieved order intake of BNOK 2.6 in the quarter. · Solstad Offshore had a utilization of 97% for vessels in operation. · Operating Income from continued operations for 2Q 2024 of MNOK 746. · EBITDA adjusted from continued operations of

Camurus’ Interim Report Second Quarter 2024

“High sales growth and strong financial performance in the second quarter” Summary second quarter 2024 April - June · Total revenues amounted to SEK 445 (674) million. Excluding a one-time revenue of SEK 369 million in Q2 2023[1], company growth was 46% (41% at CER[2]) · Product sales of Buvidal[®] were SEK 400 (305) million, an increase of 31% (28% at CER[2]) and 10% (6% at CER[2]) compared to previous quarter · Brixadi[®] royalties were SEK 45 (-) million, an increase of 73% (75% at CER[2]) compared to previous quarter · Operating result was SEK 83 (376) million ·

Interim report January-June 2024

Improved profitability in a stable quarter Second quarter 2024 – Net sales increased by 4.7 percent to SEK 7,191 million (6,869) – Organic growth adjusted for calendar effects was 2.2 percent (10.8) – Calendar effects had a positive impact of SEK 135 million on net sales and SEK 104 million on EBITA – EBITA, excl. items affecting comparability, was SEK 572 million (421) – EBITA margin, excl. items affecting comparability, was 8.0 percent (6.1) – EBITA totalled SEK 572 million (398) – EBITA margin was 8.0 percent (5.8) – EBIT (operating profit) amounted to SEK 541

Aker Horizons ASA: Second-quarter results 2024

Aker Horizons ASA (OSE: "AKH"), a developer of green energy and industry, today announced results for the second quarter 2024. Aker Horizons' net capital employed stood at NOK 7.1 billion, an increase of NOK 1.9 billion from the first quarter, mainly driven by a gain from the Aker Carbon Capture-SLB transaction. The company reported a cash position of NOK 3.1 billion and an undrawn credit facility of EUR 500 million, giving available liquidity of NOK 8.8 billion.Second quarter main developments: · Aker Carbon Capture ASA (ACC ASA) completed the transaction to combine its carbon capture

TOMRA: Invitation to 2Q 2024 Presentation

Second quarter 2024 results presentation TOMRA's second quarter 2024 results will be released on Friday, 19 July 2024. President & CEO Tove Andersen and CFO Eva Sagemo will present the results at 08:00 CEST. The presentation will be sent via live webcast: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20240719_2 Analysts and investors who would like to ask questions in the live Q&A session must register seperately for the TEAMS webinar: https://events.teams.microsoft.com/event/4dd02b3c-c739-42d2-8b4b-1accd763de91@4308d118-edd1-4300-8a37-cfeba8ad5898 A recorded

Bactiguard Holding AB’s interim report second quarter 2024

License revenues and EBITDA stabilizingSecond quarter 2024 (April – June) · Total revenue amounted to SEK 60.9 (51.2) million, an increase of SEK 9.7 million corresponding to 18.9%. · Net sales amounted to SEK 57.4 (44.2) million, an increase of SEK 13.2 million corresponding to 29.8%. Adjusted for currency effects of SEK 0.2 million, net sales increased by 30.1%. · Operating loss amounted to SEK 10.8 (67.8) million.* · EBITDA amounted to SEK 1.2 (-55.7) million.* · Net loss for the period amounted to SEK 14.3 (64.5) million.* · Loss per share, before and after dilution,

Swedbank’s Interim report for the second quarter 2024

Swedbank´s President and CEO Jens Henriksson comments: ”We create value for our customers and shareholders”.· Strong profitability and high cost efficiency  · Solid credit quality with recoveries during the quarter  · Leading position in mortgages  Contact:Annie Ho (Annie.Ho@swedbank.se), Head of Investor Relations, +46 70 343 78 15 Hannes Mård (Hannes.mard@swedbank.se), Media Relations Manager, +46 73 057 41 95 This information constitutes inside information that Swedbank is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The

Notice of annual general meeting in EQL Pharma AB

The shareholders of EQL Pharma AB, Reg. No. 556713-3425, are hereby invited to the annual general meeting to be held on Monday 19 August 2024 at 16.00 at the company’s premises at Stortorget 1 in Lund.Right to participate and notification Shareholders wishing to attend the annual general meeting must: · be registered in the company’s share register kept by Euroclear Sweden AB as of Friday 9 August 2024, and · notify the company of their intention to participate in the annual general meeting no later than Tuesday 13 August 2024 in writing by mail to EQL Pharma AB, Stortorget 1, SE-

New data report by Smartvatten shows over 50% of residential buildings experience water leakage monthly

The Annual Water Report, based on global water data combined with Smartvatten’s database of 20,000 properties and 200,000 apartments in 36 countries, shows consistent water leakages in both residential and commercial buildings. This potentially causes hundreds of thousands of extra costs for property owners annually. The rise in water prices, extreme weather conditions, and new EU regulations have made understanding water in 2024 more important than ever.Helsinki, Finland (July 16th, 2024) Smartvatten , the leading water data provider, has published its third

SEB’s results for the second quarter 2024

SEB’s operating profit for the second quarter 2024 amounted to SEK 11.8bn, with a return on equity of 17.6 per cent, a CET1 capital ratio of 19.0 per cent, and a capital management buffer of 430 basis points.  “Our result remained solid in the second quarter and asset quality was robust. While the interest rate cuts during the quarter resulted in a decrease in net interest income, we saw improved momentum in other parts of our business. For instance, we saw positive net flows in asset management across the divisions, an increase in investment banking activity and signs of improving

LUNDIN GOLD ANNOUNCES CFO TRANSITION

Vancouver, BC, July 15, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") announced today that Christopher Kololian, Chief Financial Officer, will be departing the Company on August 15, 2024. Chester See, Lundin Gold’s Senior Vice President Finance, will assume the role of CFO. Ron Hochstein, President and Chief Executive Officer of Lundin Gold stated, "On behalf of the Board of Directors and Lundin Gold, I would like to thank Christopher for his executive leadership and contributions since joining our management team. During

The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company’s commitments under incentive programmes

The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi[®]) on 14 May 2024, resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programmes resolved by the Annual General Meeting – on directed share issues of no more than 1,641,103 redeemable and convertible class C shares.The Annual General Meeting also resolved to authorise the Board of Directors to resolve on the repurchase of all issued class C shares by an offer directed to all holders of class C shares. Repurchase under this authorisation may be made on one or

Aker Solutions ASA: Transactions made under the buy-back programme

July 15, 2024 – On February 12, 2024, Aker Solutions ASA (“Aker Solutions”) announced a share buy-back program of up to NOK 500 million, with a maximum of 12.5 million shares, in the period from 12 February 2024 to 31 July 2024.Upon the successful completion of the transactions below, Aker Solutions has fulfilled the objectives of the share buy-back program. DNB, acting under an irrevocable mandate from Aker Solutions, has carried out the following transactions under the buy-back program:   +--------------------+----------+-------------+-----------------------+| Date

SEB completes latest share buyback programme and initiates new programme

SEB has completed its latest share buyback programme, under which SEK 2 billion of Class A shares have been repurchased. The Board of Directors has resolved to utilise the authorisation granted by the 19 March 2024 Annual General Meeting to initiate a new SEK 2.5 billion buyback programme of Class A shares.  On 19 March 2024, SEB announced a SEK 2 billion share buyback programme for capital management purposes. The repurchases of shares began on 20 March 2024 and ended on 12 July 2024. During this period, SEB repurchased 13,329,653 of its own Class A shares at an average price per share

Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization

Oslo, Norway, July 15, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announces that it has entered into a strategic agreement with Richard Wolf GmbH to develop and commercialize a next-generation 4K LED high-definition (HD) reusable flexible blue light cystoscope based on Richard Wolf’s System blue technology. The partnership between Photocure and Richard Wolf is focused on developing technologically advanced flexible blue light cystoscopy (BLC[®]) equipment for the global market so that physicians who treat patients with bladder cancer can offer the benefits of BLC with

Relais Group Plc: Share Repurchase 15.7.2024

Relais Group Plc  ANNOUNCEMENT  15.7.2024 Relais Group Plc: Share Repurchase 15.7.2024 In the Helsinki Stock Exchange Trade date           15.7.2024Bourse trade         BuyShare                  RELAISAmount             650 SharesAverage price/ share    13,5000 EURTotal cost            8 775,00 EUR Relais Group Plc now holds a total of 33 657 sharesincluding the shares repurchased on 15.7.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

Exel Composites Plc: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act

EXEL COMPOSITES PLC          STOCK EXCHANGE RELEASE        15 JULY 2024 AT 18:00 EESTExel Composites Plc has on 15 July 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding of funds managed by OP Fund Management Company Ltd has decreased below 5% of the voting rights and share capital in Exel Composites Plc. Through share transactions concluded on 12 July 2024, the holding of funds managed by OP Fund Management Company Ltd amounts to 5,334,412 shares representing 4.998% of the shares and voting rights of Exel

There are no items matching the current filter
There are no more items matching the current filter
Back to top